No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs566583718 |
chr9:140498165-140498166 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs12341344 |
chr9:140498172-140498173 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
3 |
rs552198124 |
chr9:140498175-140498176 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs562382242 |
chr9:140498176-140498177 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs184875675 |
chr9:140498190-140498191 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs139166615 |
chr9:140498203-140498204 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs117552873 |
chr9:140498230-140498231 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs548731055 |
chr9:140498233-140498234 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs144711688 |
chr9:140498234-140498235 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs575521209 |
chr9:140498242-140498243 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs189336833 |
chr9:140498245-140498246 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs553043142 |
chr9:140498246-140498247 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs547284705 |
chr9:140498255-140498256 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs570580185 |
chr9:140498256-140498257 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs545122531 |
chr9:140498263-140498264 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs369598015 |
chr9:140498266-140498267 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs564901875 |
chr9:140498320-140498321 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs74568194 |
chr9:140498333-140498334 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs544513324 |
chr9:140498341-140498342 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs544597249 |
chr9:140498346-140498347 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs560998812 |
chr9:140498351-140498352 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs529903929 |
chr9:140498357-140498358 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs546516093 |
chr9:140498381-140498382 |
Weak transcription Enhancers
|
Chromatin interactive region
|
4 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs559910757 |
chr9:140498390-140498391 |
Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs532495518 |
chr9:140498395-140498396 |
Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs12684680 |
chr9:140498397-140498398 |
Weak transcription Enhancers
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs552234961 |
chr9:140498408-140498409 |
Bivalent Enhancer Weak transcription Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs72765180 |
chr9:140498452-140498453 |
Bivalent Enhancer Weak transcription Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
29 |
rs369400465 |
chr9:140498566-140498567 |
Bivalent Enhancer Weak transcription Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs147878782 |
chr9:140498623-140498624 |
Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs568619089 |
chr9:140498625-140498626 |
Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs77289485 |
chr9:140498628-140498629 |
Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs111406490 |
chr9:140498643-140498644 |
Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs554454748 |
chr9:140498696-140498697 |
Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs571036665 |
chr9:140498704-140498705 |
Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs538775878 |
chr9:140498751-140498752 |
Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs558654590 |
chr9:140498756-140498757 |
Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs11789062 |
chr9:140498789-140498790 |
Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs575335878 |
chr9:140498807-140498808 |
Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Active TSS
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs199504678 |
chr9:140498810-140498811 |
Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Active TSS
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs180804100 |
chr9:140498845-140498846 |
Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Active TSS
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs554538296 |
chr9:140498920-140498921 |
Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Active TSS
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs574687910 |
chr9:140498944-140498945 |
Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Active TSS
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs540496005 |
chr9:140498984-140498985 |
Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Active TSS
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs575666389 |
chr9:140499019-140499020 |
Flanking Active TSS Enhancers Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs559947469 |
chr9:140499024-140499025 |
Flanking Active TSS Enhancers Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs141494141 |
chr9:140499027-140499028 |
Flanking Active TSS Enhancers Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs185021942 |
chr9:140499044-140499045 |
Flanking Active TSS Enhancers Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs562595193 |
chr9:140499062-140499063 |
Flanking Active TSS Enhancers Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs72765181 |
chr9:140499072-140499073 |
Flanking Active TSS Enhancers Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription
|
TF binding regionChromatin interactive region
|
5 gene(s)
|
Overlapped CNVs
|
n/a
|